Drug Profile
Research programme: psoriatic arthritis - deCODE genetics
Alternative Names: Psoriatic arthritis research programme - deCODE geneticsLatest Information Update: 15 Sep 2006
Price :
$50
*
At a glance
- Originator deCODE genetics
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Psoriatic arthritis
Most Recent Events
- 05 Feb 2003 Preclinical trials in Psoriatic arthritis in Iceland (unspecified route)